Invesco Nasdaq Future Gen 200 ETF Rating $27.62 +0.51 (+1.88%) (As of 12:31 PM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Invesco Nasdaq Future Gen 200 ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.QQQS Aggregate RatingModerate Buy 2.52Holdings in QQQS have an aggregate rating of Moderate Buy based on 289 analyst ratings issued in the past year covering 50 companies (33.6% of the portfolio).QQQS Aggregate Price Target$27.62High Prediction$27.62Average Prediction$27.62Low Prediction$27.62Holdings in QQQS have an aggregate price target of $27.62 and a range of $27.62 to $27.62 covering 50 companies (33.6% of the portfolio).QQQS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy15 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold18 Hold rating(s)Reduce4 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Future Gen 200 ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 QQQS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.48%GEVOGevo$1.39+0.4%2.4149 of 5 stars2.67$6.48 368.1%31.26%SGMOSangamo Therapeutics$1.98+1.5%2.1854 of 5 stars2.67$7.00 253.5%3Analyst Revision0.93%PACBPacific Biosciences of California$1.82+5.8%1.5305 of 5 stars2.47$3.63 99.2%15Analyst Revision0.88%CDXCChromaDex$7.64+1.9%3.7022 of 5 stars3.00$8.00 4.7%2Analyst Downgrade0.86%KODKodiak Sciences$5.85+1.0%2.9871 of 5 stars1.50$3.50 -40.2%40.85%COMMCommScope$4.49+3.5%2.7872 of 5 stars1.60$2.50 -44.3%50.83%ATOMAtomera$5.89+8.1%0.9529 of 5 stars3.00$7.00 18.8%1Positive NewsGap Down0.77%IGMSIGM Biosciences$8.94-8.5%4.7096 of 5 stars2.38$16.13 80.4%80.73%AAOIApplied Optoelectronics$36.54+7.2%1.3072 of 5 stars2.60$18.70 -48.8%5Gap UpHigh Trading Volume0.73%CORTCorcept Therapeutics$56.34+0.4%4.7045 of 5 stars3.00$65.25 15.8%5Positive News0.72%EGHT8X8$2.98+4.9%2.1937 of 5 stars2.13$2.82 -5.3%8Gap Up0.71%AMSCAmerican Superconductor$33.87+8.7%1.117 of 5 stars3.00$28.33 -16.3%3Positive News0.71%NTGRNETGEAR$24.07-0.1%3.584 of 5 stars2.00$13.00 -46.0%1Positive News0.70%IRBTiRobot$7.02+7.7%3.4659 of 5 stars2.00$13.00 85.2%2Options VolumeGap Up0.67%ATRCAtriCure$35.94-0.2%3.44 of 5 stars3.00$43.11 20.0%9Positive News0.66%SATSEchoStar$24.02+2.5%0.9434 of 5 stars2.00$19.25 -19.9%50.65%CDXSCodexis$4.36+0.7%4.2117 of 5 stars2.67$8.33 91.1%30.64%CSIQCanadian Solar$11.34-3.9%3.223 of 5 stars2.00$20.59 81.5%90.64%LOVELovesac$35.15+6.3%2.8379 of 5 stars3.00$35.17 0.0%6Analyst ForecastNews Coverage0.64%MASIMasimo$168.88+2.4%4.0735 of 5 stars2.71$163.67 -3.1%70.63%MRSNMersana Therapeutics$2.05-7.7%4.2981 of 5 stars2.88$6.00 192.7%8Analyst Revision0.63%IHRTiHeartMedia$2.44+5.2%2.7187 of 5 stars2.25$3.00 23.0%4Analyst Forecast0.63%TILEInterface$25.44-0.1%3.7504 of 5 stars2.50$20.00 -21.4%2Dividend Announcement0.62%NWLNewell Brands$8.90+0.7%4.4148 of 5 stars2.09$9.10 2.2%11Analyst Upgrade0.62%ATECAlphatec$10.13+2.0%4.8058 of 5 stars2.89$17.11 68.9%9Analyst Forecast0.61%HELEHelen of Troy$69.55+4.1%2.6608 of 5 stars2.33$75.67 8.8%3Positive News0.61%IARTIntegra LifeSciences$22.88-0.2%2.865 of 5 stars1.75$24.00 4.9%8Positive News0.61%IDCCInterDigital$184.36+1.1%2.1849 of 5 stars2.00$120.00 -34.9%3Positive News0.61%XNCRXencor$24.01+1.2%3.5491 of 5 stars3.00$35.75 48.9%80.59%IPGPIPG Photonics$75.13+2.2%4.5489 of 5 stars2.50$93.50 24.5%6Positive News0.59%IQiQIYI$1.95-10.6%3.215 of 5 stars1.80$3.45 76.9%5Gap DownHigh Trading Volume0.59%ADPTAdaptive Biotechnologies$4.49+1.6%4.409 of 5 stars2.75$6.50 44.8%4Short Interest ↓Analyst Revision0.59%AKBAAkebia Therapeutics$1.82+1.7%3.9402 of 5 stars3.00$5.75 215.9%20.58%ERIIEnergy Recovery$15.51+0.1%4.6497 of 5 stars3.00$20.33 31.1%4Analyst ForecastHigh Trading Volume0.58%ITRIItron$116.93+2.5%4.3856 of 5 stars2.69$123.92 6.0%13Analyst RevisionPositive News0.57%LITELumentum$88.25+7.0%3.0135 of 5 stars2.46$74.85 -15.2%13Insider TradeGap Up0.57%MNKDMannKind$6.86-0.3%3.47 of 5 stars3.14$8.67 26.3%7Insider Trade0.57%DMRCDigimarc$32.02+2.1%0.633 of 5 stars2.50$34.00 6.2%20.57%BVSBioventus$11.42+0.1%2.7337 of 5 stars3.00$13.00 13.8%3Positive News0.57%PTCTPTC Therapeutics$43.07+2.6%2.5619 of 5 stars2.33$42.00 -2.5%15Analyst Downgrade0.56%RMBSRambus$54.61+3.1%4.193 of 5 stars3.00$71.60 31.1%50.56%VIAVViavi Solutions$10.05+2.3%3.427 of 5 stars2.44$10.44 3.9%9Analyst Forecast0.56%SONOSonos$13.35+3.1%1.0736 of 5 stars2.00$15.00 12.4%30.56%SSYSStratasys$9.56+2.8%3.6781 of 5 stars2.80$11.40 19.2%50.56%AXGNAxoGen$13.04+1.1%2.7178 of 5 stars3.00$15.00 15.0%40.56%BANDBandwidth$18.83+4.7%4.3382 of 5 stars2.43$28.33 50.5%70.55%KPTIKaryopharm Therapeutics$0.77-0.6%3.9733 of 5 stars3.00$5.00 549.4%40.55%RBBNRibbon Communications$3.89+0.8%4.59 of 5 stars3.00$5.83 50.0%2Positive News0.55%OMCLOmnicell$43.61+4.3%3.1135 of 5 stars2.33$52.00 19.2%6Analyst ForecastAnalyst RevisionNews Coverage0.55%PCRXPacira BioSciences$17.43+2.3%4.0043 of 5 stars2.20$23.50 34.8%10Positive News This page (NASDAQ:QQQS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Future Gen 200 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Future Gen 200 ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
